| 2000 |
PICOT (GLRX3) was identified as a PKCθ-interacting protein via yeast two-hybrid; its N-terminal thioredoxin homology domain is required for the interaction with PKC. Overexpression of full-length PICOT (but not N- or C-terminal fragments alone) inhibited JNK activation and AP-1/NF-κB transcription in T cells. |
Yeast two-hybrid, colocalization, transient overexpression with reporter assays |
The Journal of biological chemistry |
Medium |
10636891
|
| 2006 |
Yeast Grx3 and Grx4 interact with Aft1 both in vivo and in vitro, and their Grx domains are required for promoting Aft1 nuclear export; the grx3grx4 double mutant accumulates intracellular iron and constitutively activates Aft1 target genes. |
Co-immunoprecipitation, in vitro binding, GFP localization, genetic deletion analysis |
Journal of cell science |
Medium |
17074835
|
| 2006 |
PICOT (GLRX3) overexpression in cardiomyocytes blocked hypertrophic responses to endothelin-1 and phenylephrine; transgenic mice with cardiac-specific PICOT overexpression showed increased ventricular function and cardiomyocyte contractility associated with increased myofilament Ca2+ responsiveness and enhanced SERCA Ca2+ reuptake. |
Adenoviral gene transfer, transgenic mouse model, cardiomyocyte contractility assays, Ca2+ handling analysis |
Circulation research |
High |
16809552
|
| 2008 |
PICOT directly interacts with muscle LIM protein (MLP) via its C-terminal half (PICOT-C), colocalizes with MLP at the Z-disc, and disrupts MLP-calcineurin interaction in a dose-dependent manner, thereby abrogating calcineurin-NFAT signaling and inhibiting cardiac hypertrophy. |
GST pull-down, mass spectrometry, coimmunoprecipitation, immunofluorescence, reporter assays, transgenic mouse pressure overload model |
Circulation research |
High |
18258855
|
| 2008 |
PICOT(+/-) mice show exacerbated pressure-overload cardiac hypertrophy with enhanced calcineurin-NFAT signaling, reduced cardiomyocyte contractility, hypophosphorylation of phospholamban, and reduced SERCA activity, confirming PICOT as a negative regulator of cardiac hypertrophy and a positive inotropic regulator in vivo. |
Gene trap knockout mouse, pressure overload model, signaling assays, contractility measurements |
Journal of molecular and cellular cardiology |
High |
18929570
|
| 2009 |
Yeast Grx3 and Grx4, upon coexpression with Fra2 (BolA homologue), form a [2Fe-2S]-bridged heterodimeric complex; the cluster is coordinated by the active site cysteine of Grx3/4, glutathione, and a histidine residue from Fra2. Without Fra2, Grx3/4 forms a [2Fe-2S]-bridged homodimer. This complex can serve as a signal to control the iron regulon. |
Reconstitution in E. coli, UV-visible absorption/CD, resonance Raman, EPR, ENDOR, Mossbauer, EXAFS spectroscopy, mutagenesis |
Biochemistry |
High |
19715344
|
| 2009 |
Fission yeast Grx4 physically interacts with Crm1 (exportin) and with the iron regulatory protein Php4; deletion of grx4 renders Php4 constitutively nuclear and active. Grx4 and Crm1 are required for iron-dependent nuclear export of Php4. |
Co-immunoprecipitation, bimolecular fluorescence complementation (BiFC), two-hybrid assays, leptomycin B treatment, GFP imaging |
The Journal of biological chemistry |
High |
19502236
|
| 2010 |
Human GLRX3 (PICOT) binds two bridging [2Fe-2S]2+ clusters in a homodimeric complex, coordinated by active site cysteinyl residues of its two Grx domains and non-covalently bound glutathione. The [2Fe-2S]2+ clusters are lost upon treatment with ferricyanide or S-nitroso glutathione, suggesting redox-induced cluster dissociation as a potential activation mechanism. Co-immunoprecipitation of 55-iron confirmed iron binding under physiological conditions. |
UV-visible spectroscopy, CD, EPR, 55Fe co-immunoprecipitation, treatment with oxidants |
Biochemical and biophysical research communications |
High |
20226171
|
| 2011 |
S. pombe Grx4 is required for iron-dependent inhibition of Fep1 transcription factor under low-iron conditions. Grx4's TRX domain interacts strongly and constitutively with Fep1's C-terminal region (requiring Cys35), while the GRX domain interacts weakly and iron-dependently with Fep1's N-terminal region (requiring Cys172). |
Deletion mapping, co-immunoprecipitation, yeast genetics, chromatin binding assays |
Eukaryotic cell |
High |
21421748
|
| 2011 |
S. cerevisiae Grx3/Grx4 and Fe-S cluster protein Dre2 contribute to in vivo diferric tyrosyl radical (Fe2(III)-Tyr•) cofactor assembly in ribonucleotide reductase subunit Rnr2; growth defects of rnr4 mutants are enhanced by grx3/grx4 deficiency, placing Grx3/4 in the pathway of iron loading into Rnr2. |
Genetic epistasis, EPR-based Tyr• measurement, iron loading assays, spheroplast complementation |
The Journal of biological chemistry |
Medium |
21931161
|
| 2011 |
Mouse Grx3 knockout results in embryonic lethality at E12.5; Grx3-deficient MEFs and HeLa knockdown cells show impaired cell cycle progression at G2/M with increased binucleated cells, establishing a direct role in mitotic exit. |
Knockout mouse (embryonic lethal), flow cytometry cell cycle analysis, siRNA knockdown, immunofluorescence |
The FEBS journal |
High |
21575136
|
| 2011 |
PICOT (GLRX3) physically interacts with anamorsin (CIAPIN1/AM) via the N-terminal regions of both proteins; inhibition of this interaction impairs cell growth. |
Yeast two-hybrid, co-immunoprecipitation, cell growth assays |
Biochemical and biophysical research communications |
Low |
21513700
|
| 2011 |
Fission yeast Grx4 physically interacts with Fep1 in vivo, and mutation of Cys172 (active site of GRX domain) abolishes iron-dependent gene regulation and the Grx4-Fep1 interaction detected by BiFC, indicating that Fe-S cofactor binding in the GRX domain is critical for Fep1 modulation. |
Co-immunoprecipitation, BiFC, site-directed mutagenesis, transcription assays |
Biochemical and biophysical research communications |
Medium |
21531205
|
| 2012 |
PICOT directly binds the catalytic domain of PKCζ via its N-terminal thioredoxin-like domain; purified PICOT inhibits PKCζ kinase activity in vitro. PICOT-mediated PKCζ inhibition down-regulates PKCα and PP2A activities, leading to increased phosphorylation of phospholamban (PLB) and troponin I/T, enhancing SERCA2a activity and cardiomyocyte contractility. |
Protein pull-down, in vitro kinase assay, PKCζ inhibitor peptide, AAV-mediated overexpression, cardiomyocyte contractility measurements |
Journal of molecular and cellular cardiology |
High |
22449794
|
| 2013 |
PICOT is a caspase-3 cleavage substrate; in vitro cleavage assays show specific cleavage at DRLD(101)/G and EELD(226)/T. Endogenous PICOT is cleaved by caspase-3 during staurosporine- and etoposide-induced apoptosis. PICOT overexpression (WT or cleavage-resistant D101A/D226A) accelerates etoposide-induced caspase-3 activation, while PICOT knockdown blocks it. |
In vitro caspase cleavage assay, site-directed mutagenesis, pan-caspase inhibitor treatment, siRNA knockdown |
Biochemical and biophysical research communications |
High |
23415866
|
| 2013 |
Zebrafish depletion of Grx3 severely impairs hemoglobin maturation. Silencing human GLRX3 in HeLa cells decreases activities of cytosolic Fe/S proteins including iron regulatory protein 1 (IRP1), leading to decreased ferritin and increased transferrin receptor levels, a signature of cellular iron starvation despite unimpaired iron uptake. |
Zebrafish morpholino knockdown, siRNA in HeLa cells, enzyme activity assays, Western blot for IRP1/ferritin/transferrin receptor |
Molecular biology of the cell |
High |
23615448
|
| 2015 |
Human GRX3 and apo BOLA2 form a heterotrimeric complex (two BOLA2 molecules + one GRX3 molecule) that binds two [2Fe-2S]2+ clusters, each bridged between one BOLA2 and one GRX3 Grx domain; this complex transfers both [2Fe-2S]2+ clusters to apo anamorsin to produce its mature holo form, establishing GRX3-BOLA2 as a [2Fe-2S] cluster transfer component in cytosolic Fe/S protein maturation. |
NMR spectroscopy, UV-visible/CD spectroscopy, in vitro reconstitution and cluster transfer assays |
Journal of the American Chemical Society |
High |
26613676
|
| 2016 |
Yeast Grx3/4 physically interact with Sir2 sirtuin in vivo and can reverse S-glutathionylation of Sir2 (at cysteines in the catalytic domain) in vitro and in vivo, restoring Sir2 deacetylase activity after disulfide stress; this establishes Grx3/4 as Sir2 thiol-reductases that regulate telomeric silencing via S-deglutathionylation. |
In vitro deglutathionylation assay, in vivo S-glutathionylation detection, co-immunoprecipitation, site-directed mutagenesis, silencing assay |
Free radical biology & medicine |
Medium |
27085841
|
| 2016 |
Yeast Grx3 and Grx4 physically interact with the MAPK Slt2 in vivo and in vitro, forming Fe/S-bridged complexes where cysteines of Grx3/4 active sites, glutathione, and specific Slt2 cysteines provide ligands. Loss of Grx3/4 impairs Slt2 phosphorylation and Rlm1 transcription upon oxidative stress; Grx4 is the predominant regulator of Slt2 phosphorylation under oxidative conditions. |
Co-immunoprecipitation (in vivo and in vitro), spectroscopic analysis, mutagenesis, viability and kinase activity assays |
Free radical biology & medicine |
Medium |
28007574
|
| 2017 |
S. pombe Grx4 and its partner Fra2 form a [2Fe-2S]-bridged heterodimer with specific spectroscopic properties; conserved cysteines in Grx4 (Cys172) and Php4 (Cys221, Cys227) are necessary for Fe-S cluster binding and stable Grx4-Php4 complex formation. Grx4 controls Php4 function through binding of a bridging [2Fe-2S] cluster. |
UV-visible/CD/EPR spectroscopy, in vitro reconstitution, mutagenesis, size exclusion chromatography, in vitro titration |
Metallomics |
High |
28725905
|
| 2018 |
Crystal structures of the Trx domain (Grx3Trx) and Grx domain (Grx3Grx) of yeast Grx3 were solved; structural analyses revealed that the Trx domain contributes to glutathione S-transferase activity via an inter-domain disulfide between Cys37 and Cys176. NMR titration, pull-down, and SPR assays showed that Fra2 forms a noncovalent heterodimer with Grx3 via an interface between Fra2's helix-turn-helix motif and Grx3Grx's C-terminal segment, independent of the Fe-S-covalent heterodimer. |
X-ray crystallography, NMR spectroscopy, GST pull-down, surface plasmon resonance, activity assays |
Journal of molecular biology |
High |
29524511
|
| 2018 |
PICOT interacts with EED (a PRC2 core component) via each of its two C-terminal PICOT/Grx homology domains; PICOT and EED co-immunoprecipitate from Jurkat T cell nuclear extracts and partially colocalize in nuclei. PICOT knockdown reduces H3K27me3 at the MYT1 gene promoter, indicating PICOT modulates PRC2-dependent chromatin silencing. |
Yeast two-hybrid, GST pull-down, reciprocal coimmunoprecipitation, immunofluorescence/confocal microscopy, ChIP (H3K27me3) |
Biochemical and biophysical research communications |
Medium |
30595380
|
| 2019 |
The conserved CDC motif cysteines of yeast Aft2 are essential for [2Fe-2S] cluster binding and Aft2 dimerization, and one of the two cysteines is required for interaction with the [2Fe-2S]-Grx3-Bol2 (Bol2=Fra2 homolog) complex; cluster transfer from Grx3-Bol2 to Aft2 likely occurs through a ligand exchange mechanism. |
Size exclusion chromatography, circular dichroism spectroscopy, mutagenesis, in vitro cluster transfer assays |
Journal of biological inorganic chemistry |
Medium |
31493153
|
| 2019 |
PICOT-deficient Jurkat T cells show impaired γH2AX foci formation and reduced phosphorylation of ATR, Chk1, and Chk2 in response to genotoxic drugs and radiation; partial localization of PICOT at γH2AX foci at DNA double-strand break sites was observed. PICOT acts as a positive upstream regulator of ATR-dependent DNA damage signaling, independent of ROS levels. |
siRNA knockdown, immunofluorescence/confocal microscopy, flow cytometry, Western blot for phospho-ATR/Chk1/Chk2/γH2AX |
Cellular signalling |
Medium |
31176019
|
| 2019 |
PICOT knockdown in Jurkat T cells reduces H3K27me3 at the CCND2 gene promoter, decreases EED and EZH2 occupancy at CCND2, and leads to increased CCND2 (cyclin D2) mRNA and protein expression, establishing PICOT binding to chromatin-associated EED as a modulator of PRC2-mediated repression of CCND2. |
Coimmunoprecipitation, ChIP (H3K27me3, EED, EZH2), siRNA knockdown, RT-PCR, Western blot |
Cell death & disease |
Medium |
31527584
|
| 2020 |
Human GLRX3 transfers its [2Fe-2S]2+ clusters to monomeric apo NUBP1 (CIA machinery component); in the presence of glutathione as reductant, the clusters are reductively coupled to form [4Fe-4S]2+ clusters on both N-terminal (CX13CX2CX5C) and C-terminal (CPXC) motifs of NUBP1. Cluster binding at the C-terminal motif promotes NUBP1 dimerization; GLRX3 acts as a [2Fe-2S] cluster chaperone in the early CIA pathway. |
In vitro reconstitution, UV-visible/CD/EPR spectroscopy, size exclusion chromatography, cluster transfer assays |
Journal of the American Chemical Society |
High |
32429669
|
| 2020 |
Human GLRX3 (PICOT) interacts with human GMP synthase (hGMPs) via conserved residues that bridge Fe/S clusters and glutathione; this interaction downregulates the Gcn2/ISR stress pathway. The interaction and pathway function are conserved in yeast (Grx3/Grx4 with GUA1/ScGMPs) and human GLRX3/hGMPs can functionally complement yeast Grx3/Grx4. |
Yeast humanization complementation, two-hybrid, co-expression, genetic pathway assays (Gcn2 readouts) |
Applied and environmental microbiology |
Medium |
32414791
|
| 2023 |
S. pombe Grx4-Fra2 heterodimer facilitates [2Fe-2S] cluster removal from the Fep1 transcription repressor via unidirectional cluster transfer from Fep1 to Grx4-Fra2 in the presence of GSH; Fra2 His66 and Cys29 serve as Fe-S cluster ligands in the Grx4-Fra2 complex. This defines the Fe-S cluster-dependent mechanism of Fep1 inactivation under low iron. |
In vitro reconstitution, CD spectroscopy, mutagenesis, in vivo transcription assays, growth assays |
The Journal of biological chemistry |
High |
37923140
|
| 2025 |
In HeLa cells with CRISPR/Cas9 GLRX3 knockout, IRP1 is activated (indicating iron starvation due to impaired iron metabolism). Rescue experiments show that only a Trx-GrxA construct (first Trx-like domain + first Grx domain) restores the phenotype to wild-type levels; the individual domains alone are insufficient, and the second Grx domain (GrxB) is not required for this function. |
CRISPR/Cas9 knockout, domain rescue transfection, IRP1 activity assay |
FEBS letters |
Medium |
40400140
|
| 2026 |
In satellite glial cells of aged mice, GLRX3 upregulation catalyzes deglutathionylation of HMGB1 at Cys106 via its catalytic Cys148 residue; this converts HMGB1 into a TLR4-MD2 agonist, triggering neuronal NF-κB signaling and upregulation of TRPA1 and TRPV2 channels in nociceptors, sustaining neuropathic pain. Satellite glial cell-targeted knockdown of GLRX3 restored HMGB1 glutathionylation and reversed pain phenotype in aged mice. |
Single-nucleus RNA sequencing, redox proteomics, site-directed mutagenesis (Cys148), in vivo knockdown, behavioral pain assays, TLR4 signaling assays |
Brain |
Medium |
42007893
|